Literature DB >> 25440058

Reducing macrophage proteoglycan sulfation increases atherosclerosis and obesity through enhanced type I interferon signaling.

Philip L S M Gordts1, Erin M Foley2, Roger Lawrence1, Risha Sinha1, Carlos Lameda-Diaz1, Liwen Deng1, Ryan Nock1, Christopher K Glass3, Ayca Erbilgin4, Aldons J Lusis4, Joseph L Witztum5, Jeffrey D Esko6.   

Abstract

Heparan sulfate proteoglycans (HSPGs) are an important constituent of the macrophage glycocalyx and extracellular microenvironment. To examine their role in atherogenesis, we inactivated the biosynthetic gene N-acetylglucosamine N-deacetylase-N-sulfotransferase 1 (Ndst1) in macrophages and crossbred the strain to Ldlr(-/-) mice. When placed on an atherogenic diet, Ldlr(-/-)Ndst1(f/f)LysMCre(+) mice had increased atherosclerotic plaque area and volume compared to Ldlr(-/-) mice. Diminished sulfation of heparan sulfate resulted in enhanced chemokine expression; increased macrophages in plaques; increased expression of ACAT2, a key enzyme in cholesterol ester storage; and increased foam cell conversion. Motif analysis of promoters of upregulated genes suggested increased type I interferon signaling, which was confirmed by elevation of STAT1 phosphorylation induced by IFN-β. The proinflammatory macrophages derived from Ndst1(f/f)LysMCre(+) mice also sensitized the animals to diet-induced obesity. We propose that macrophage HSPGs control basal activation of macrophages by maintaining type I interferon reception in a quiescent state through sequestration of IFN-β.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25440058      PMCID: PMC4254584          DOI: 10.1016/j.cmet.2014.09.016

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  38 in total

1.  Macrophages create an acidic extracellular hydrolytic compartment to digest aggregated lipoproteins.

Authors:  Abigail S Haka; Inna Grosheva; Ethan Chiang; Adina R Buxbaum; Barbara A Baird; Lynda M Pierini; Frederick R Maxfield
Journal:  Mol Biol Cell       Date:  2009-10-07       Impact factor: 4.138

2.  Myeloid type I interferon signaling promotes atherosclerosis by stimulating macrophage recruitment to lesions.

Authors:  Pieter Goossens; Marion J J Gijbels; Alma Zernecke; Wouter Eijgelaar; Monique N Vergouwe; Ingeborg van der Made; Joris Vanderlocht; Linda Beckers; Wim A Buurman; Mat J A P Daemen; Ulrich Kalinke; Christian Weber; Esther Lutgens; Menno P J de Winther
Journal:  Cell Metab       Date:  2010-08-04       Impact factor: 27.287

Review 3.  Constitutive type I interferon modulates homeostatic balance through tonic signaling.

Authors:  Daniel J Gough; Nicole L Messina; Christopher J P Clarke; Ricky W Johnstone; David E Levy
Journal:  Immunity       Date:  2012-02-24       Impact factor: 31.745

4.  Peroxisome proliferator-activated receptor-α activation promotes macrophage reverse cholesterol transport through a liver X receptor-dependent pathway.

Authors:  Kazuhiro Nakaya; Junichiro Tohyama; Snehal U Naik; Hiroyuki Tanigawa; Colin MacPhee; Jeffrey T Billheimer; Daniel J Rader
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-03-24       Impact factor: 8.311

5.  ApoE regulates hematopoietic stem cell proliferation, monocytosis, and monocyte accumulation in atherosclerotic lesions in mice.

Authors:  Andrew J Murphy; Mani Akhtari; Sonia Tolani; Tamara Pagler; Nora Bijl; Chao-Ling Kuo; Mi Wang; Marie Sanson; Sandra Abramowicz; Carrie Welch; Andrea E Bochem; Jan Albert Kuivenhoven; Laurent Yvan-Charvet; Alan R Tall
Journal:  J Clin Invest       Date:  2011-10       Impact factor: 14.808

Review 6.  Heparan sulfate proteoglycans.

Authors:  Stephane Sarrazin; William C Lamanna; Jeffrey D Esko
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-07-01       Impact factor: 10.005

7.  A comprehensive compositional analysis of heparin/heparan sulfate-derived disaccharides from human serum.

Authors:  Wei Wei; Milady R Niñonuevo; Anish Sharma; Lieza M Danan-Leon; Julie A Leary
Journal:  Anal Chem       Date:  2011-04-19       Impact factor: 6.986

8.  Evolutionary differences in glycosaminoglycan fine structure detected by quantitative glycan reductive isotope labeling.

Authors:  Roger Lawrence; Sara K Olson; Robert E Steele; Lianchun Wang; Rahul Warrior; Richard D Cummings; Jeffrey D Esko
Journal:  J Biol Chem       Date:  2008-09-24       Impact factor: 5.157

9.  Syndecan-4 mediates macrophage uptake of group V secretory phospholipase A2-modified LDL.

Authors:  Boris B Boyanovsky; Preetha Shridas; Michael Simons; Deneys R van der Westhuyzen; Nancy R Webb
Journal:  J Lipid Res       Date:  2008-12-03       Impact factor: 5.922

10.  Increased expression of heparanase in symptomatic carotid atherosclerosis.

Authors:  C Osterholm; L Folkersen; M Lengquist; F Pontén; T Renné; Jp Li; U Hedin
Journal:  Atherosclerosis       Date:  2012-10-23       Impact factor: 5.162

View more
  32 in total

Review 1.  Sex as a Biological Variable in Atherosclerosis.

Authors:  Joshua J Man; Joshua A Beckman; Iris Z Jaffe
Journal:  Circ Res       Date:  2020-04-23       Impact factor: 17.367

Review 2.  Proteoglycans as Immunomodulators of the Innate Immune Response to Lung Infection.

Authors:  Inkyung Kang; Mary Y Chang; Thomas N Wight; Charles W Frevert
Journal:  J Histochem Cytochem       Date:  2018-01-12       Impact factor: 2.479

Review 3.  The heparan sulfate proteoglycan grip on hyperlipidemia and atherosclerosis.

Authors:  Philip L S M Gordts; Jeffrey D Esko
Journal:  Matrix Biol       Date:  2018-05-24       Impact factor: 11.583

Review 4.  A role for proteoglycans in vascular disease.

Authors:  Thomas N Wight
Journal:  Matrix Biol       Date:  2018-02-27       Impact factor: 11.583

Review 5.  Targeting heparin and heparan sulfate protein interactions.

Authors:  Ryan J Weiss; Jeffrey D Esko; Yitzhak Tor
Journal:  Org Biomol Chem       Date:  2017-06-27       Impact factor: 3.876

6.  Protein tyrosine phosphatase σ regulates autoimmune encephalomyelitis development.

Authors:  Yosuke Ohtake; Weimin Kong; Rashad Hussain; Makoto Horiuchi; Michel L Tremblay; Doina Ganea; Shuxin Li
Journal:  Brain Behav Immun       Date:  2017-05-27       Impact factor: 7.217

7.  HS3ST1 genotype regulates antithrombin's inflammomodulatory tone and associates with atherosclerosis.

Authors:  Nicole C Smits; Takashi Kobayashi; Pratyaksh K Srivastava; Sladjana Skopelja; Julianne A Ivy; Dustin J Elwood; Radu V Stan; Gregory J Tsongalis; Frank W Sellke; Peter L Gross; Michael D Cole; James T DeVries; Aaron V Kaplan; John F Robb; Scott M Williams; Nicholas W Shworak
Journal:  Matrix Biol       Date:  2017-01-23       Impact factor: 11.583

8.  PPARγ Deficiency Suppresses the Release of IL-1β and IL-1α in Macrophages via a Type 1 IFN-Dependent Mechanism.

Authors:  Kassandra J Weber; Madeline Sauer; Li He; Eric Tycksen; Gowri Kalugotla; Babak Razani; Joel D Schilling
Journal:  J Immunol       Date:  2018-08-24       Impact factor: 5.422

9.  Protein Tyrosine Phosphatase PTPRS Is an Inhibitory Receptor on Human and Murine Plasmacytoid Dendritic Cells.

Authors:  Anna Bunin; Vanja Sisirak; Hiyaa S Ghosh; Lucja T Grajkowska; Z Esther Hou; Michelle Miron; Cliff Yang; Michele Ceribelli; Noriko Uetani; Laurence Chaperot; Joel Plumas; Wiljan Hendriks; Michel L Tremblay; Hans Häcker; Louis M Staudt; Peter H Green; Govind Bhagat; Boris Reizis
Journal:  Immunity       Date:  2015-07-28       Impact factor: 31.745

10.  Endothelial heparan sulfate deficiency reduces inflammation and fibrosis in murine diabetic nephropathy.

Authors:  Ditmer T Talsma; Kirankumar Katta; Marieke A B Ettema; Berna Kel; Marion Kusche-Gullberg; Moh R Daha; Coen A Stegeman; Jacob van den Born; Lianchun Wang
Journal:  Lab Invest       Date:  2018-01-12       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.